Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users.
To investigate the features of various hepatitis virus infection in intravenous drug users (IVDU), we conducted an epidemiological survey of hepatitis viruses including hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV) and hepatitis G virus (HGV) in IVDU. The correlation of TH lymphocyte cytokine and hepatitis virus infection was examined. A study population of 406 IVDU consisted of 383 males and 23 females. HBV-DNA and HCV-RNA were detected by fluorescence quantitative polymerase chain reaction. HBsAg, HBeAg, anti-HBc, anti-HCV, HDV-Ag and anti-HGV were assayed by ELISA. The levels of cytokines of TH1 and TH2 were measured by ELISA. The similar indices taken from 102 healthy persons served as controls. The infection rate of each virus among IVDU was 36.45 % for HBV, 69.7 % for HCV, 2.22 % for HDV, and 1.97 % for HGV, respectively. The co-infection rate of HBV and HCV was detected in 113 of 406 (27.83 %). In contrast, among controls, the infection rate was 17.65 % for HBV and 0 % for the other hepatitis viruses. The levels of PHA-induced cytokines (IFN-gamma and IL-4) and the level of serum IL-2 were obviously decreased in IVDU. On the other hand, the level of serum IL-4 was increased. The IFN-gamma level was continuously decreased when the IVDU was infected with HBV/HCV. In conclusion, HBV and HCV infection were common in this population of IVDU and they had led to a high incidence of impaired TH1 cytokine levels.
Li
Jianrong
J
Department of Pathogenic Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang
Jing
J
Tian
Kunlun
K
Wang
Yixin
Y
Zhang
Lei
L
Huang
Hanju
H
D000293:Adolescent; D000328:Adult; D002681:China / Q000453:epidemiology; D016207:Cytokines / Q000097:blood*; D004279:DNA, Viral / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D018178:Flaviviridae Infections / Q000453:epidemiology*; D029407:GB virus C / Q000254:growth & development; D006508:Hepatitis Antibodies / Q000097:blood; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology; D003699:Hepatitis D / Q000097:blood / Q000453:epidemiology; D006525:Hepatitis, Viral, Human / Q000097:blood / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood; D015819:Substance Abuse, Intravenous / Q000097:blood / Q000821:virology*; D006377:T-Lymphocytes, Helper-Inducer / Q000378:metabolism / Q000821:virology
D016207:Cytokines; D004279:DNA, Viral; D006508:Hepatitis Antibodies; D012367:RNA, Viral